8.A.16.2.1 Transmembrane AMPA receptor (AMPAR) regulatory proteins, also called voltage-dependent Ca2+ channel γ2 subunits, TARPγ2, CACNG2, gamma-2 or Stargazin; regulate Ca(v)2.2 (TC# 1.A.1.11.19) as well as GIRK (TC# 1.A.2.1.3) (Tselnicker and Dascal 2010). TARPγ2 and TARPγ7 (8.A.16.2.5) can substitute for each other (Yamazaki et al. 2015). TARPs also enhance AMPAR function,
altering ligand efficacy and receptor gating kinetics and shaping the postsynaptic response. Stargazin rescues gating deficiencies in AMPARs
carrying mutations that destabilize the closed-cleft states of the ligand-binding domain (LBD),
suggesting that stargazin stabilizes closed LBD
states (MacLean et al. 2014). For Ca2+-permeable AMPARs, stargazin enhances
receptor function by increasing single-channel conductance, slowing channel gating, increasing
calcium permeability, and relieving the voltage-dependent block by endogenous intracellular
polyamines (McGee et al. 2015). TARPs alter the conformations of pore-forming subunits and
thereby affect antagonist interactions (Cokić and Stein 2008). By shifting the balance between AMPAR activation and desensitization, TARPs markedly facilitate the transduction of spillover-mediated synaptic signaling (Coombs et al. 2017). Stargazin plays a role in AMPA receptor trafficking through the early compartments of the biosynthetic pathway (Vandenberghe et al. 2005). Stargazin in complex with PSD-95 or PSD-95-assembled postsynaptic complexes form highly concentrated and dynamic condensates via phase separation, reminiscent of stargazin/PSD-95-mediated AMPAR synaptic clustering and trapping (Zeng et al. 2019). Positive allosteric modulators (PAMs) of AMPA receptors boost cognitive
performance in clinical studies, and mibampator and BIIB104 discriminate
between AMPARs complexed with distinct TARPs, and particularly those
with lower stargazin/gamma2 efficacy such as BIIB104 (Ishii et al. 2020). TARPs modulate receptor-mediated paired-pulse depression and recovery from desensitization (Devi et al. 2020).
|
Accession Number: | Q9Y698 |
Protein Name: | CACNG2 |
Length: | 323 |
Molecular Weight: | 35966.00 |
Species: | Homo sapiens (Human) [9606] |
Number of TMSs: | 4 |
Location1 / Topology2 / Orientation3: |
Membrane1 / Multi-pass membrane protein2 |
Substrate |
NONE |
---|
Genevestigator: |
Q9Y698
|
eggNOG: |
prNOG14835
|
HEGENOM: |
HBG564649
|
RefSeq: |
NP_006069.1
|
Entrez Gene ID: |
10369
|
Pfam: |
PF00822
|
OMIM: |
602911 gene
|
KEGG: |
hsa:10369
|
|
[1] “Identification and cloning of putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits: neurologic implications.” Black J.L. III et.al. 10221464
[2] “A genome annotation-driven approach to cloning the human ORFeome.” Collins J.E. et.al. 15461802
[3] “The DNA sequence of human chromosome 22.” Dunham I. et.al. 10591208
[4] “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).” The MGC Project Team et.al. 15489334
|
|
1: MGLFDRGVQM LLTTVGAFAA FSLMTIAVGT DYWLYSRGVC KTKSVSENET SKKNEEVMTH
61: SGLWRTCCLE GNFKGLCKQI DHFPEDADYE ADTAEYFLRA VRASSIFPIL SVILLFMGGL
121: CIAASEFYKT RHNIILSAGI FFVSAGLSNI IGIIVYISAN AGDPSKSDSK KNSYSYGWSF
181: YFGALSFIIA EMVGVLAVHM FIDRHKQLRA TARATDYLQA SAITRIPSYR YRYQRRSRSS
241: SRSTEPSHSR DASPVGIKGF NTLPSTEISM YTLSRDPLKA ATTPTATYNS DRDNSFLQVH
301: NCIQKENKDS LHSNTANRRT TPV